quantitative
Analysis v1
Strong Support

If HIV patients keep taking tesamorelin for a full year, their dangerous belly fat drops by about 18% compared to when they started — but we don’t know how much better that is than just stopping the drug, because the placebo group didn’t stay on it for a year.

81
Pro
0
Against

Evidence from Studies

Supporting (1)

81

Community contributions welcome

The study found that HIV patients who took tesamorelin daily for a year lost about 18% of their dangerous belly fat, and when they stopped taking it, the fat came back — so the drug caused the loss, not just time or luck.

Contradicting (0)

0

Community contributions welcome

No contradicting evidence found